SUPPLIERS
Pfanstiehl, a global leader in the manufacture of cGMP high purity, low endotoxin, low metals (HPLE-LM)TM injectable grade excipients.
Click Us!
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 19538
Submission : 2006-06-20
Status : Active
Type : IV
Pfanstiehl, a global leader in the manufacture of cGMP high purity, low endotoxin, low metals (HPLE-LM)TM injectable grade excipients.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 37676
Submission : 2022-11-11
Status : Active
Type : IV
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 16697
Submission : 2003-07-09
Status : Active
Type : IV
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 18881
Submission : 2005-10-15
Status : Active
Type : IV
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 36348
Submission : 2021-11-03
Status : Active
Type : IV
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 11797
Submission : 1995-10-27
Status : Inactive
Type : IV
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 14975
Submission : 2000-07-31
Status : Inactive
Type : IV
NDC Package Code : 51552-1527
Start Marketing Date : 2016-09-15
End Marketing Date : 2027-07-07
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
NDC Package Code : 51552-1530
Start Marketing Date : 2016-12-28
End Marketing Date : 2025-11-08
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
NDC Package Code : 51552-1414
Start Marketing Date : 2012-04-01
End Marketing Date : 2027-04-15
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]LISTED SUPPLIERS
FINISHED DOSAGE FORMULATIONS
FDF DOSSIERS SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Listed Dossiers
SUCROSE
Route : ORAL
CAS :
UNII : C151H8M554
Potency Amount : 0
Potency Unit : NA
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
SUCROSE
Route : ORAL
CAS :
UNII : C151H8M554
Potency Amount : 22.26
Potency Unit : %
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
SUCROSE
Route : ORAL
CAS :
UNII : C151H8M554
Potency Amount : 85.46
Potency Unit : %
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
SUCROSE
Route : ORAL
CAS :
UNII : C151H8M554
Potency Amount : 182.4
Potency Unit : MG
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
SUCROSE
Route : ORAL
CAS :
UNII : C151H8M554
Potency Amount : 527.43
Potency Unit : MG
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
SUCROSE
Route : ORAL
CAS :
UNII : C151H8M554
Potency Amount : 0
Potency Unit : NA
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
SUCROSE
Route : ORAL
CAS :
UNII : C151H8M554
Potency Amount : 17.6
Potency Unit : MG
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
SUCROSE
Route : ORAL
CAS :
UNII : C151H8M554
Potency Amount : 1195.44
Potency Unit : MG/5ML
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
SUCROSE
Route : ORAL
CAS :
UNII : C151H8M554
Potency Amount : 166
Potency Unit : MG/5ML
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
SUCROSE
Route : ORAL
CAS :
UNII : C151H8M554
Potency Amount : 2323.3
Potency Unit : MG/1PKT
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
EXCIPIENTS BY APPLICATIONS
Coating Systems Additives
Taste Masking
Coloring Agents
Thickeners And Stabilizers
Parenteral
Digital Content
DATA COMPILATION #PharmaFlow
MARKET PLACE
REF. STANDARDS & IMPURITIES
